Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

8-K - Current report

Form Type: 8-K

Filing Date: 2013-07-15

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2013-06-27

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2013-06-17

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2013-06-14

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2013-06-14

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2013-06-10

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2013-06-10

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2013-06-06

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2013-06-06

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2013-06-04

View Filing